Pittenger & Anderson Inc’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Pittenger & Anderson Inc’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-4,500	Closed	-$6K	–	429
2015 Q4	$6K	Hold	4,500	–	–	﹤0.01%	382
2015 Q3	$51K	Hold	4,500	–	–	0.01%	304
2015 Q2	$8K	Hold	4,500	–	–	﹤0.01%	386
2015 Q1	$6K	Buy	+4,500	New	+$6K	﹤0.01%	392
2014 Q2	–	Sell	-18,000	Closed	-$45K	–	392
2014 Q1	$45K	Hold	18,000	–	–	0.01%	287
2013 Q4	$89K	Hold	18,000	–	–	0.01%	281
2013 Q3	$41K	Buy	18,000 +2,000	+13%	+$4.56K	0.01%	276
2013 Q2	$36K	Buy	+16,000	New	+$36K	0.01%	275

Other funds holding RXII

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

BIM

BlackRock Investment Management Wilmington, Delaware $86.4B AUM 16.83% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TCIM

TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return

Pittenger & Anderson Inc's RXII Position: Q1 2016 in Review

Pittenger & Anderson Inc sold out of GALENA BIOPHARMA INC COM (RXII) in Q1 2016, closing a stake of 4,500 shares — an estimated $6K sold.

Pittenger & Anderson Inc first reported a position in RXII in Q2 2013 and held it in 8 quarters. The position peaked at $89K in Q4 2013. 71 funds tracked by Wall St. Rank hold RXII as of Q1 2016.

Pittenger & Anderson Inc reported no remaining GALENA BIOPHARMA INC COM position as of Q1 2016 after selling out during the quarter.
Pittenger & Anderson Inc sold 4,500 GALENA BIOPHARMA INC COM shares in Q1 2016, an estimated $6K.
Pittenger & Anderson Inc first reported a position in GALENA BIOPHARMA INC COM in Q2 2013 and held it in 8 quarters.
Pittenger & Anderson Inc's GALENA BIOPHARMA INC COM position peaked at $89K in Q4 2013.
71 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q1 2016.

Based on Pittenger & Anderson Inc's 13F filing for Q1 2016, filed 13 May 2016.